2024 Must-Read Collection from BSI journals

We are pleased to share this collection of must-read articles from the BSI's official journals, Immunotherapy Advances, Discovery Immunology and Clinical & Experimental Immunology. These are the articles that have been viewed and cited more than any others from our journals in the past 12 months. All articles are open access and free to read.

Immunotherapy Advances

Figure from 'Adrenergic signaling regulation of macrophage function: do we understand it yet?'
Figure from 'Adrenergic signaling regulation of macrophage function: do we understand it yet?'

Adrenergic signaling regulation of macrophage function: do we understand it yet?

DOI:10.1093/immadv/ltac010

Beatriz Marton Freire, Filipe Menegatti de Melo, Alexandre S Basso

Characterization of sabatolimab, a novel immunotherapy with immuno-myeloid activity directed against TIM-3 receptor

DOI:10.1093/immadv/ltac019

Stephanie Schwartz, Nidhi Patel, Tyler Longmire, Pushpa Jayaraman, Xiaomo Jiang, Hongbo Lu, Lisa Baker, Janelle Velez, Radha Ramesh, Anne-Sophie Wavreille, Melanie Verneret, Hong Fan, Tiancen Hu, Fangmin Xu, John Taraszka, Marc Pelletier, Joy Miyashiro, Mikael Rinne, Glenn Dranoff, Catherine Sabatos-Peyton, Viviana Cremasco

Plasma exchange for severe immune-related adverse events from checkpoint inhibitors: an early window of opportunity?

DOI:10.1093/immadv/ltac012

Tamiko R Katsumoto, Kalin L Wilson, Vinay K Giri, Han Zhu, Shuchi Anand, Kavitha J Ramchandran, Beth A Martin, Muharrem Yunce, Srikanth Muppidi

Figure from paper
Figure from 'Prevalence of inverse psoriasis subtype with immune checkpoint inhibitors'

Prevalence of inverse psoriasis subtype with immune checkpoint inhibitors

DOI:10.1093/immadv/ltac016

Abdulhadi Jfri, Bonnie Leung, Jordan T Said, Yevgeniy Semenov, Nicole R LeBoeuf

Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes

DOI:10.1093/immadv/ltac002

D Tatovic, M A McAteer, J Barry, A Barrientos, K Rodríguez Terradillos, I Perera, E Kochba, Y Levin, M Dul, S A Coulman, J C Birchall, C von Ruhland, A Howell, R Stenson, M Alhadj Ali, S D Luzio, G Dunseath, W Y Cheung, G Holland, K May, J R Ingram, M M U Chowdhury, F S Wong, R Casas, C Dayan, J Ludvigsson

Combination of genetically engineered T cells and immune checkpoint blockade for the treatment of cancer

DOI:10.1093/immadv/ltac005

Rafaela Rossetti, Heloísa Brand, Sarah Caroline Gomes Lima, Izadora Peter Furtado, Roberta Maraninchi Silveira, Daianne Maciely Carvalho Fantacini, Dimas Tadeu Covas, Lucas Eduardo Botelho de Souza

Target isoforms are an overlooked challenge and opportunity in chimeric antigen receptor cell therapy 

DOI:10.1093/immadv/ltac009

Mike Bogetofte Barnkob, Kristoffer Vitting-Seerup, Lars Rønn Olsen

Figure from 'Targeting the high affinity receptor, FcγRI, in autoimmune disease, neuropathy, and cancer'
Figure from 'Targeting the high affinity receptor, FcγRI, in autoimmune disease, neuropathy, and cancer'

Targeting the high affinity receptor, FcγRI, in autoimmune disease, neuropathy, and cancer

DOI:10.1093/immadv/ltac011

Tosca Holtrop, Kevin Budding, Arianne M Brandsma, Jeanette H W Leusen

Engineering CAR-NK cells: how to tune innate killer cells for cancer immunotherapy

DOI:10.1093/immadv/ltac003

Dayane Schmidt, Sima Ebrahimabadi, Kauan Ribeiro de Sena Gomes, Graziela de Moura Aguiar, Mariane Cariati Tirapelle, Renata Nacasaki Silvestre, Júlia Teixeira Cottas de Azevedo, Dimas Tadeu Covas, Virginia Picanço-Castro

Challenges in tolerogenic dendritic cell therapy for autoimmune diseases: the route of administration

DOI:10.1093/immadv/ltad012

María José Mansilla, Catharien M U Hilkens, Eva M Martínez-Cáceres

 

Clinical & Experimental Immunology

Figure from 'Extracellular vesicles containing PD-L1 contribute to CD8+ T-cell immune suppression and predict poor outcomes in small cell lung cancer'
Figure from 'Extracellular vesicles containing PD-L1 contribute to CD8+ T-cell immune suppression and predict poor outcomes in small cell lung cancer'

Extracellular vesicles containing PD-L1 contribute to CD8+ T-cell immune suppression and predict poor outcomes in small cell lung cancer

DOI:10.1093/cei/uxac006

Xiaoyan Dou, Yan Hua, Zhaowu Chen, Fengmei Chao, Ming Li

Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK

DOI:10.1093/cei/uxac008

Adrian M Shields, Ariharan Anantharachagan, Gururaj Arumugakani, Kenneth Baker, Sameer Bahal, Helen Baxendale, William Bermingham, Malini Bhole, Evon Boules, Philip Bright, Charu Chopra, Lucy Cliffe, Betsy Cleave, John Dempster, Lisa Devlin, Fatima Dhalla, Lavanya Diwakar, Elizabeth Drewe, Christopher Duncan see more

Gut microbiome and autoimmune disorders

DOI:10.1093/cei/uxac057

Walaa Abdelaty Shaheen, Mohammed Nabil Quraishi and Tariq H Iqbal

IL-2-based approaches to Treg enhancement

DOI:10.1093/cei/uxac105

Ffion Harris,  Yoana Arroyo Berdugo and  Timothy Tree

Figure from 'Immunotherapeutic targeting of activating natural killer cell receptors and their ligands in cancer'
Figure from 'Immunotherapeutic targeting of activating natural killer cell receptors and their ligands in cancer'

Immunotherapeutic targeting of activating natural killer cell receptors and their ligands in cancer

DOI:10.1093/cei/uxac028

Matthias Peipp, Katja Klausz, Ammelie Svea Boje, Tobias Zeller, Stefan Zielonka, Christian Kellner

B cell contribution to immunometabolic dysfunction and impaired immune responses in obesity

DOI:10.1093/cei/uxac079

Kristine Oleinika, Baiba Slisere, Diego Catalán, Elizabeth C Rosser

Inborn errors of human IKAROS: LOF and GOF variants associated with primary immunodeficiency

DOI:10.1093/cei/uxac109

Hye Sun Kuehn, Brigette Boast, Sergio D Rosenzweig

Antibodies as biomarkers for cancer risk: a systematic review

DOI:10.1093/cei/uxac030

Maria J Monroy-Iglesias, Silvia Crescioli, Kerri Beckmann, Nga Le, Sophia N Karagiannis, Mieke Van Hemelrijck, Aida Santaolalla

Figure from 'The regulatory role of eosinophils in viral, bacterial, and fungal infections'
Figure from 'The regulatory role of eosinophils in viral, bacterial, and fungal infections'

The regulatory role of eosinophils in viral, bacterial, and fungal infections

DOI:10.1093/cei/uxac038

Pratibha Gaur, Ilan Zaffran, Tresa George, Fidan Rahimli Alekberli, Micha Ben-Zimra, Francesca Levi-Schaffer

Exosomal PD-L1 predicts response with immunotherapy in NSCLC patients

DOI:10.1093/cei/uxac045

Yuting Wang, Xiaomin Niu, Yirui Cheng, Yanshuang Zhang, Liliang Xia, Weiliang Xia, Shun Lu

Discovery Immunology

Figure from 'Protection from T cell-dependent colitis by the helminth-derived immunomodulatory mimic of transforming growth factor-β, Hp-TGM'
Figure from 'Protection from T cell-dependent colitis by the helminth-derived immunomodulatory mimic of transforming growth factor-β, Hp-TGM'

Protection from T cell-dependent colitis by the helminth-derived immunomodulatory mimic of transforming growth factor-β, Hp-TGM

DOI:10.1093/discim/kyad001

Danielle J Smyth, Madeleine P J White, Chris J C Johnston, Anne-Marie Donachie see more

 

Nur77-Tempo mice reveal T cell steady state antigen recognition

DOI:10.1093/discim/kyac009

Thomas A E Elliot, Emma K Jennings, David A J Lecky, Sophie Rouvray, Gillian M Mackie, Lisa Scarfe, Lozan Sheriff, Masahiro Ono, Kendle M Maslowski, David Bending

Figure from 'Expression of antimicrobial host defence peptides in the central nervous system during health and disease'
Figure from 'Expression of antimicrobial host defence peptides in the central nervous system during health and disease'

Expression of antimicrobial host defence peptides in the central nervous system during health and disease

DOI:10.1093/discim/kyac003

Katie J Smith, Emily Gwyer Findlay

Looking into the IL-1 of the storm: are inflammasomes the link between immunothrombosis and hyperinflammation in cytokine storm syndromes?

DOI:10.1093/discim/kyac005

Tara A Gleeson, Erik Nordling, Christina Kaiser, Catherine B Lawrence, David Brough, Jack P Green, Stuart M Allan

Figure from 'NKG2D signaling regulates IL-17A-producing γδT cells in mice to promote cancer progression '
Figure from 'NKG2D signaling regulates IL-17A-producing γδT cells in mice to promote cancer progression '

NKG2D signaling regulates IL-17A-producing γδT cells in mice to promote cancer progression

DOI:10.1093/discim/kyac002

Sophie Curio, Sarah C Edwards, Toshiyasu Suzuki, Jenny McGovern see more

Join our author community

The BSI journals offer a home for papers from a wide range of immunologists, while providing essential income to support the Society’s charitable activities. Support the BSI by considering one of our journals for your next submission.

Read more about publishing in Clinical & Experimental Immunology, Discovery Immunology, and Immunotherapy Advances.